ID: MRFR/LS/4737-HCR | February 2021 | Region: Global | 100 pages
Market Scenario
The global singleplex immunoassay market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global singleplex immunoassay market is expected to register a CAGR ~ 8.4 % during the forecast period of 2018–2023.
Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification. For instance, Thermo Fisher Scientific’s QuantiGene Singleplex assay is developed to detect original RNA or DNA population using signal amplification.
Numerous factors such as growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, and rising use of immunoassay in oncology fuels the growth of global singleplex immunoassay. Additionally, that rising prevalence of chronic diseases will push the demand for singleplex immunoassay technologies.
Moreover, the growing awareness about immunoassay, enhanced focus on diagnostic testing, and increasing government assistance are continuously contributing to the growth of the global singleplex immunoassay market.
Despite the drivers, some factors such as the stringent FDA regulations, the emergence of multiplex immunoassays, the complex procedure of testing, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent.
Company Profiles
Segmentation
The global singleplex immunoassay market is segmented on the basis of the product and service, type, technology, application, and end-user.
On the basis of the product and services, the market is classified as consumables, instruments, and others.
The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays, and others.
On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others.
The global singleplex immunoassay market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are further segmented into drug discovery & development and biomarker discovery and validation. The clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and metabolism & endocrinology disorders.
On the basis of the end-user, the global singleplex immunoassay market is segmented as pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories and others.
Geographically, global singleplex immunoassay market has been segmented into America, Europe, Asia-Pacific, and the Middle East & Africa. The Americas singleplex immunoassay market is further segmented into North America, and South America. North America is further classified as the US and Canada.
The Europe singleplex immunoassay market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UKUK, Italy, Spain, and the Rest of Western Europe.
The Asia-Pacific singleplex immunoassay market is segmented into Japan, China, India, Republic of Korea, Australia, and Rest of Asia-Pacific.
The Middle East & Africa singleplex immunoassay market is segmented into the Middle East, and Africa.
Regional Market Summary
Global Singleplex Immunoassay Market, by Region Market Share, 2017 (%)
Source: MRFR Analysis
The global singleplex immunoassay market consists of four regions: Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas is expected to dominate the singleplex immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases. According to the statistics suggested by the Centers for Disease Control (CDC) and Prevention, in 2014, around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States.
Europe is anticipated to hold the second position in the global singleplex immunoassay market. It is expected that the rising automation in an immunoassay, increasing prevalence of chronic diseases, funding provided by the government, and private organizations towards research & development are anticipated to drive the European market.
The Asia-Pacific singleplex immunoassay market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is the fastest growing in singleplex immunoassay market. Major factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in the biotechnology sector, increasing healthcare expenditure influences the market in this region. Additionally, according to the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was USD 170.4 billion, i.e., 3.6 % higher than the expenditure of 2014-2015.
The Middle East and Africa hold the least share in the global singleplex immunoassay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.
Research Methodology
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global singleplex immunoassay market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.
Global Singleplex Immunoassay Market, by Product and Service
Global Singleplex Immunoassay Market, by Type
Global Singleplex Immunoassay Market, by Technology
Global Singleplex Immunoassay Market, by Application
Global Singleplex Immunoassay Market, by End-user
Global Singleplex Immunoassay Market, by Region
Intended Audience
Frequently Asked Questions (FAQ) :
Singleplex Immunoassay Market is projected to grow at an 8.4% CAGR between 2018-2023.
The Americas is expected to lead the Singleplex Immunoassay Market.
Rising prevalence of chronic diseases and growing biotechnology sector is boosting market growth.
Poor healthcare system may limit market growth.
Different strategies used by market players to create a dominance in the Singleplex Immunoassay Market growth include mergers, collaborations, product developments, and R&D.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Singleplex Immunoassay Market, by Product and Service
6.1 Introduction
6.2 Consumables
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.3 Instruments
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
6.4 Others
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 7. Global Singleplex Immunoassay Market, by Type
7.1 Introduction
7.2 Protein-Based Assays
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.3 Nucleic Acid Based Assays
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.4 Cell-Based Assays
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
7.5 Others
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 8. Global Singleplex Immunoassay Market, by Technology
8.1 Introduction
8.2 Flow Cytometry
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.3 Fluorescence Detection
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
8.4 Others
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 9. Global Singleplex Immunoassay Market, by Application
9.1 Introduction
9.2 Research & Development
9.2.1 Drug Discovery & Development
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
9.2.2 Biomarker Discovery & validation
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
9.3 Clinical Diagnostics
9.3.1 Infectious Diseases
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
9.3.2 Cancer
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
9.3.3 Cardiovascular Diseases
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
9.3.4 Autoimmune Diseases
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
9.3.5 Nervous System Disorders
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
9.3.6 Metabolism & Endocrinology Disorders
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
9.4 Others
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 10. Global Singleplex Immunoassay Market, by End-User
10.1 Introduction
10.2 Pharmaceuticals & Biotechnology Companies
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
10.3 Hospital & Research Institutes
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
10.4 Reference Laboratories
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
10.5 Others
Market Estimates & Forecast, by Region, 2018–2023
Market Estimates & Forecast, by Country, 2018–2023
Chapter 11. Global Singleplex Immunoassay Market, by Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 US
11.2.1.2 Canada
11.2.2 South America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 France
11.3.1.3 Italy
11.3.1.4 Spain
11.3.1.5 UK
11.3.1.6 Rest of Western Europe
11.3.2 Eastern Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Republic of Korea
11.4.6 Rest of Asia Pacific
11.5 The Middle East & Africa
11.5.1 The Middle East
11.5.2 Africa
Chapter 12. Company Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Key Development & Strategies
Chapter 13. Company Profiles
13.1 Luminex
13.1.1 Company Overview
13.1.2 Product Overview
13.1.3 Financials Overview
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.2 Thermo Fisher Scientific
13.2.1 Company Overview
13.2.2 Product Overview
13.2.3 Financial Overview
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 Illumina
13.3.1 Company Overview
13.3.2 Product Overview
13.3.3 Financial Overview
13.3.4 Key Development
13.3.5 SWOT Analysis
13.4 Bio-Rad Laboratories
13.4.1 Company Overview
13.4.2 Technology/Business Segment Overview
13.4.3 Financial Overview
13.4.4 Key Development
13.4.5 SWOT Analysis
13.5 QIAGEN N. V
13.5.1 Company Overview
13.5.2 Product Overview
13.5.3 Financial overview
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.6 Abcam
13.6.1 Company Overview
13.6.2 Product Overview
13.6.3 Financial Overview
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.7 Becton Dickinson and Company
13.7.1 Overview
13.7.2 Product Overview
13.7.3 Financial Overview
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.8 Merck Life Sciences
13.8.1 Overview
13.8.2 Product/ Technology Overview
13.8.3 Financials
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.9 Agilent Technologies
13.9.1 Overview
13.9.2 Product Overview
13.9.3 Financials
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.10 Quanterix
13.10.1 Overview
13.10.2 Product Overview
13.10.3 Financials
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.11 Bio-Techne
13.11.1 Overview
13.11.2 Product Overview
13.11.3 Financials
13.11.4 Key Developments
13.11.5 SWOT Analysis
13.12 Olink
13.12.1 Overview
13.12.2 Product Overview
13.12.3 Financials
13.12.4 Key Developments
13.12.5 SWOT Analysis
13.13 Seegene
13.13.1 Overview
13.13.2 Product Overview
13.13.3 Financials
13.13.4 Key Developments
13.13.5 SWOT Analysis
13.14 BioVendor
13.14.1 Overview
13.14.2 Product Overview
13.14.3 Financials
13.14.4 Key Developments
13.14.5 SWOT Analysis
13.15 Others
Chapter 14 MRFR Conclusion
14.1 Key Findings
14.1.1 From CEO’s View Point
14.1.2 Unmet Needs of the Market
14.2 Key Companies to Watch
14.3 Prediction of the Arthroscopy Instruments Industry
Chapter 15 Appendix
LIST OF TABLES
Table 1 Global Singleplex Immunoassay Market Synopsis, 2018–2023
Table 2 Global Singleplex Immunoassay Market Estimates and Forecast, 2018–2023, (USD
Million)
Table 3 Global Singleplex Immunoassay Market, by Region, 2018–2023, (USD Million)
Table 4 Global Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD
Million)
Table 5 Global Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)
Table 6 Global Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)
Table 7 Global Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)
Table 8 Global Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)
Table 9 North America Global Singleplex Immunoassay Market, by Product and Service, 2018–
2023, (USD Million)
Table 10 North America Global Singleplex Immunoassay Market, by Type, 2018–2023, (USD
Million)
Table 11 North America Global Singleplex Immunoassay Market, by Technology, 2018–2023, (USD
Million)
Table 12 North America Global Singleplex Immunoassay Market, by Application, 2018–2023, (USD
Million)
Table 13 North America Global Singleplex Immunoassay Market, by End-User, 2018–2023, (USD
Million)
Table 14 US Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD Million)
Table 15 US Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)
Table 16 US Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)
Table 17 US Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)
Table 18 US Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)
Table 19 Canada Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD
Million)
Table 20 Canada Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)
Table 21 Canada Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)
Table 22 Canada Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)
Table 23 Canada Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)
Table 24 South America Singleplex Immunoassay Market, by Product and Service, 2018–2023,
(USD Million)
Table 25 South America Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)
Table 26 South America Singleplex Immunoassay Market, by Technology, 2018–2023, (USD
Million)
Table 27 South America Singleplex Immunoassay Market, by Application, 2018–2023, (USD
Million)
Table 28 South America Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)
Table 29 Europe Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD
Million)
Table 30 Europe Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)
Table 31 Europe Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)
Table 32 Europe Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)
Table 33 Europe Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)
Table 34 Western Europe Singleplex Immunoassay Market, by Product and Service, 2018–2023,
(USD Million)
Table 35 Western Europe Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)
Table 36 Western Europe Singleplex Immunoassay Market, by Technology, 2018–2023, (USD
Million)
Table 37 Western Europe Singleplex Immunoassay Market, by Application, 2018–2023, (USD
Million)
Table 38 Western Europe Singleplex Immunoassay Market, by End-User, 2018–2023, (USD
Million)
Table 39 Eastern Europe Singleplex Immunoassay Market, by Product and Service, 2018–2023,
(USD Million)
Table 40 Eastern Europe Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)
Table 41 Eastern Europe Singleplex Immunoassay Market, by Technology, 2018–2023, (USD
Million)
Table 42 Eastern Europe Singleplex Immunoassay Market, by Application, 2018–2023, (USD
Million)
Table 43 Eastern Europe Singleplex Immunoassay Market, by End-User, 2018–2023, (USD
Million)
Table 44 Asia Pacific Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD
Million)
Table 45 Asia Pacific Singleplex Immunoassay Market, by Type, 2018–2023, (USD Million)
Table 46 Asia Pacific Singleplex Immunoassay Market, by Technology, 2018–2023, (USD Million)
Table 47 Asia Pacific Singleplex Immunoassay Market, by Application, 2018–2023, (USD Million)
Table 48 Asia Pacific Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)
Table 49 Middle East & Africa Singleplex Immunoassay Market, by Product and Service, 2018–
2023, (USD Million)
Table 50 Middle East & Africa Singleplex Immunoassay Market, by Type, 2018–2023, (USD
Million)
Table 51 Middle East & Africa Singleplex Immunoassay Market, by Technology, 2018–2023, (USD
Million)
Table 52 Middle East & Africa Singleplex Immunoassay Market, by Application, 2018–2023, (USD
Million)
Table 53 Middle East & Africa Singleplex Immunoassay Market, by End-User, 2018–2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Singleplex Immunoassay Market
Figure 3 Segmentation Market Dynamics for Global Singleplex Immunoassay Market
Figure 4 Global Singleplex Immunoassay Market Share, by Product and Service 2017
Figure 5 Global Singleplex Immunoassay Market Share, by Type 2017
Figure 6 Global Singleplex Immunoassay Market Share, by Technology 2017
Figure 7 Global Singleplex Immunoassay Market Share, by Application 2017
Figure 8 Global Singleplex Immunoassay Market Share, by End-User, 2017
Figure 9 Global Singleplex Immunoassay Market Share, by Region, 2017
Figure 10 North America Singleplex Immunoassay Market Share, by Country, 2017
Figure 11 Europe Singleplex Immunoassay Market Share, by Country, 2017
Figure 12 Asia Pacific Singleplex Immunoassay Market Share, by Country, 2017
Figure 13 Middle East & Africa Singleplex Immunoassay Market Share, by Country, 2017
Figure 14 Global Singleplex Immunoassay Market: Company Share Analysis, 2017 (%)
Figure 15 Luminex: Key Financials
Figure 16 Luminex: Segmental Revenue
Figure 17 Luminex: Geographical Revenue
Figure 18 Thermo Fisher Scientific: Key Financials
Figure 19 Thermo Fisher Scientific: Segmental Revenue
Figure 20 Thermo Fisher Scientific: Geographical Revenue
Figure 21 Illumina::Key Financials
Figure 22 Illumina: Segmental Revenue
Figure 23 Illumina: Geographical Revenue
Figure 24 Bio-Rad Laboratories: Key Financials
Figure 25 Bio-Rad Laboratories: Segmental Revenue
Figure 26 Bio-Rad Laboratories: Geographical Revenue
Figure 27 QIAGEN N. V:Key Financials
Figure 28 QIAGEN N. V: Segmental Revenue
Figure 29 QIAGEN N. V. Geographical Revenue
Figure 30 Abcam: Key Financials
Figure 31 Abcam: Segmental Revenue
Figure 32 Abcam: Geographical Revenue
Figure 33 Becton Dickinson and Company: Key Financials
Figure 34 Becton Dickinson and Company: Segmental Revenue
Figure 35 Becton Dickinson and Company: Geographical Revenue
Figure 36 Merck Life Sciences: Key Financials
Figure 37 Merck Life Sciences: Segmental Revenue
Figure 38 Merck Life Sciences: Geographical Revenue
Figure 39 Agilent Technologies: Key Financials
Figure 40 Agilent Technologies: Segmental Revenue
Figure 41 Agilent Technologies: Geographical Revenue
Figure 42 Quanterix: Key Financials
Figure 43 Quanterix: Segmental Revenue
Figure 44 Quanterix: Geographical Revenue
Figure 45 Bio-Techne: Key Financials
Figure 46 Bio-Techne: Segmental Revenue
Figure 47 Bio-Techne: Geographical Revenue
Figure 48 Olink: Key Financials
Figure 49 Olink: Segmental Revenue
Figure 50 Olink: Geographical Revenue
Figure 51 Seegene: Key Financials
Figure 52 Seegene: Segmental Revenue
Figure 53 Seegene: Geographical Revenue
Figure 54 BioVendor: Key Financials
Figure 55 BioVendor: Segmental Revenue
Figure 56 BioVendor: Geographical Revenue